Free Trial

Alpha Tau Medical (DRTS) Competitors

Alpha Tau Medical logo
$14.48 -0.41 (-2.75%)
Closing price 04:00 PM Eastern
Extended Trading
$14.74 +0.25 (+1.76%)
As of 06:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DRTS vs. TFX, HAE, ITGR, LIVN, and IRTC

Should you buy Alpha Tau Medical stock or one of its competitors? Alpha Tau Medical's main competitors and comparable companies include Teleflex (TFX), Haemonetics (HAE), Integer (ITGR), LivaNova (LIVN), and iRhythm Technologies (IRTC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Alpha Tau Medical compare to Teleflex?

Teleflex (NYSE:TFX) and Alpha Tau Medical (NASDAQ:DRTS) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends, media sentiment and earnings.

Teleflex presently has a consensus price target of $155.20, suggesting a potential upside of 23.76%. Alpha Tau Medical has a consensus price target of $15.40, suggesting a potential upside of 3.43%. Given Teleflex's stronger consensus rating and higher probable upside, research analysts plainly believe Teleflex is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teleflex
1 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
2.67
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.38

Alpha Tau Medical has lower revenue, but higher earnings than Teleflex. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teleflex$1.99B2.67-$905.64M-$23.29N/A
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A

Teleflex has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market.

Alpha Tau Medical has a net margin of 0.00% compared to Teleflex's net margin of -39.67%. Teleflex's return on equity of 11.93% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Teleflex-39.67% 11.93% 5.44%
Alpha Tau Medical N/A -138.12%-81.68%

In the previous week, Teleflex and Teleflex both had 2 articles in the media. Teleflex's average media sentiment score of 0.43 beat Alpha Tau Medical's score of 0.00 indicating that Teleflex is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teleflex
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alpha Tau Medical
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

95.6% of Teleflex shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 0.7% of Teleflex shares are owned by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Teleflex beats Alpha Tau Medical on 9 of the 14 factors compared between the two stocks.

How does Alpha Tau Medical compare to Haemonetics?

Alpha Tau Medical (NASDAQ:DRTS) and Haemonetics (NYSE:HAE) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, institutional ownership, earnings, valuation and profitability.

Alpha Tau Medical presently has a consensus target price of $15.40, suggesting a potential upside of 3.43%. Haemonetics has a consensus target price of $99.78, suggesting a potential downside of 4.84%. Given Alpha Tau Medical's higher probable upside, equities research analysts clearly believe Alpha Tau Medical is more favorable than Haemonetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.38
Haemonetics
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 99.7% of Haemonetics shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by insiders. Comparatively, 2.1% of Haemonetics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Alpha Tau Medical has a beta of 1.22, meaning that its stock price is 22% more volatile than the broader market. Comparatively, Haemonetics has a beta of 0.61, meaning that its stock price is 39% less volatile than the broader market.

In the previous week, Haemonetics had 5 more articles in the media than Alpha Tau Medical. MarketBeat recorded 7 mentions for Haemonetics and 2 mentions for Alpha Tau Medical. Haemonetics' average media sentiment score of 0.19 beat Alpha Tau Medical's score of 0.00 indicating that Haemonetics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Haemonetics
2 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Haemonetics has a net margin of 7.12% compared to Alpha Tau Medical's net margin of 0.00%. Haemonetics' return on equity of 27.55% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -138.12% -81.68%
Haemonetics 7.12%27.55%9.65%

Haemonetics has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A
Haemonetics$1.33B3.58$97.31M$2.0451.40

Summary

Haemonetics beats Alpha Tau Medical on 13 of the 16 factors compared between the two stocks.

How does Alpha Tau Medical compare to Integer?

Integer (NYSE:ITGR) and Alpha Tau Medical (NASDAQ:DRTS) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings and risk.

Integer currently has a consensus price target of $109.86, suggesting a potential downside of 13.24%. Alpha Tau Medical has a consensus price target of $15.40, suggesting a potential upside of 3.43%. Given Alpha Tau Medical's stronger consensus rating and higher possible upside, analysts clearly believe Alpha Tau Medical is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
13 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.07
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.38

Integer has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.85B2.32$102.81M$3.6634.60
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A

Integer has a beta of 0.58, indicating that its share price is 42% less volatile than the broader market. Comparatively, Alpha Tau Medical has a beta of 1.22, indicating that its share price is 22% more volatile than the broader market.

99.3% of Integer shares are owned by institutional investors. Comparatively, 2.7% of Alpha Tau Medical shares are owned by institutional investors. 1.1% of Integer shares are owned by insiders. Comparatively, 39.5% of Alpha Tau Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Integer had 3 more articles in the media than Alpha Tau Medical. MarketBeat recorded 5 mentions for Integer and 2 mentions for Alpha Tau Medical. Integer's average media sentiment score of 0.40 beat Alpha Tau Medical's score of 0.00 indicating that Integer is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
0 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alpha Tau Medical
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Integer has a net margin of 6.97% compared to Alpha Tau Medical's net margin of 0.00%. Integer's return on equity of 12.79% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Integer6.97% 12.79% 6.48%
Alpha Tau Medical N/A -138.12%-81.68%

Summary

Integer beats Alpha Tau Medical on 10 of the 15 factors compared between the two stocks.

How does Alpha Tau Medical compare to LivaNova?

Alpha Tau Medical (NASDAQ:DRTS) and LivaNova (NASDAQ:LIVN) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings.

2.7% of Alpha Tau Medical shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 39.5% of Alpha Tau Medical shares are owned by company insiders. Comparatively, 0.4% of LivaNova shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Alpha Tau Medical has a beta of 1.22, meaning that its share price is 22% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market.

In the previous week, Alpha Tau Medical and Alpha Tau Medical both had 2 articles in the media. LivaNova's average media sentiment score of 0.34 beat Alpha Tau Medical's score of 0.00 indicating that LivaNova is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
LivaNova
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Alpha Tau Medical presently has a consensus price target of $15.40, indicating a potential upside of 3.43%. LivaNova has a consensus price target of $84.13, indicating a potential upside of 10.07%. Given LivaNova's stronger consensus rating and higher possible upside, analysts plainly believe LivaNova is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.38
LivaNova
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.55

Alpha Tau Medical has higher earnings, but lower revenue than LivaNova. Alpha Tau Medical is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A
LivaNova$1.39B3.03-$242.47M$3.3822.61

LivaNova has a net margin of 12.82% compared to Alpha Tau Medical's net margin of 0.00%. LivaNova's return on equity of 16.35% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -138.12% -81.68%
LivaNova 12.82%16.35%7.76%

Summary

LivaNova beats Alpha Tau Medical on 11 of the 14 factors compared between the two stocks.

How does Alpha Tau Medical compare to iRhythm Technologies?

Alpha Tau Medical (NASDAQ:DRTS) and iRhythm Technologies (NASDAQ:IRTC) are both healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations and risk.

Alpha Tau Medical has a net margin of 0.00% compared to iRhythm Technologies' net margin of -1.69%. iRhythm Technologies' return on equity of 10.11% beat Alpha Tau Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A -138.12% -81.68%
iRhythm Technologies -1.69%10.11%1.53%

Alpha Tau Medical has a beta of 1.22, indicating that its stock price is 22% more volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.45, indicating that its stock price is 45% more volatile than the broader market.

Alpha Tau Medical has higher earnings, but lower revenue than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Alpha Tau Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A
iRhythm Technologies$825.34M4.36-$44.55M-$0.43N/A

Alpha Tau Medical currently has a consensus target price of $15.40, indicating a potential upside of 3.43%. iRhythm Technologies has a consensus target price of $180.07, indicating a potential upside of 65.07%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts plainly believe iRhythm Technologies is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alpha Tau Medical
2 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.38
iRhythm Technologies
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94

In the previous week, iRhythm Technologies had 8 more articles in the media than Alpha Tau Medical. MarketBeat recorded 10 mentions for iRhythm Technologies and 2 mentions for Alpha Tau Medical. iRhythm Technologies' average media sentiment score of 0.20 beat Alpha Tau Medical's score of 0.00 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alpha Tau Medical
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
iRhythm Technologies
2 Very Positive mention(s)
1 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

2.7% of Alpha Tau Medical shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by insiders. Comparatively, 1.0% of iRhythm Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

iRhythm Technologies beats Alpha Tau Medical on 11 of the 16 factors compared between the two stocks.

Get Alpha Tau Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DRTS vs. The Competition

MetricAlpha Tau MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.31B$5.40B$7.10B$13.40B
Dividend YieldN/A1.81%2.54%17.38%
P/E Ratio-13.9225.29273.9726.32
Price / SalesN/A68.46634.43100.33
Price / CashN/A32.7327.2234.74
Price / Book16.455.9711.096.35
Net Income-$42.63M$146.97M$3.49B$381.26M
7 Day Performance-4.67%-0.77%-2.31%-0.62%
1 Month Performance-3.66%-4.84%-7.06%-4.85%
1 Year Performance243.13%1.12%5.65%1.12%

Alpha Tau Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DRTS
Alpha Tau Medical
1.4742 of 5 stars
$14.48
-2.8%
$15.40
+6.4%
+245.5%$1.31BN/AN/A121
TFX
Teleflex
4.395 of 5 stars
$125.97
-1.1%
$155.20
+23.2%
-4.3%$5.40B$1.99BN/A15,500
HAE
Haemonetics
1.7022 of 5 stars
$105.79
+0.0%
$99.78
-5.7%
+108.1%$4.81B$1.33B51.863,009
ITGR
Integer
2.2665 of 5 stars
$126.35
0.0%
$109.86
-13.0%
+20.3%$4.30B$1.85B34.5211,000
LIVN
LivaNova
2.7579 of 5 stars
$76.99
-0.3%
$84.13
+9.3%
+43.2%$4.25B$1.39B22.783,300

Related Companies and Tools


This page (NASDAQ:DRTS) was last updated on 10/6/2026 by MarketBeat.com Staff.
From Our Partners